To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

266.10a day ago
277.80a day ago
arrow

LOWER/UPPER CIRCUITS

249.75
305.25
arrow
Infinium Pharmachem Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 15.05%, in the last year to ₹157.83 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteInterest Coverage Ratio,is 5.05, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
noteDebt to Equity Ratio,is zero as the company is debt-free.
View more
Infinium Pharmachem Limited is well focused to Iodine chemistry this is the only core area of it. It is working as Contract Research and Manufacturing Services (CRAMS), but its domain is very restricted to Iodine chemistry it revolves around Iodine derivatives or Iodination. It manufactures supply wide range of superior quality Iodine Derivatives API Since 2003. It is also providing fully integrated customized services from RD to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals various other chemical Industries. It supplies range of Iodine derivatives on Order to Made basis only.
personal

Grow your wealth with more research recommendations

+91